BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37382029)

  • 1. The expression and function of the B7 family in Helicobacter pylori infection and gastric carcinogenesis process.
    Zhang Y; Zhao Z; Fu W; Ding S
    Helicobacter; 2023 Aug; 28(4):e12999. PubMed ID: 37382029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer.
    Hong JB; Zuo W; Wang AJ; Lu NH
    Int J Med Sci; 2016; 13(4):298-303. PubMed ID: 27076787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK-STAT1 Signaling Pathway Is an Early Response to
    Li X; Pan K; Vieth M; Gerhard M; Li W; Mejías-Luque R
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456965
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Helicobacter pylori infection on Bax protein expression in patients with gastric precancerous lesions.
    Liu HF; Liu WW; Wang GA; Teng XC
    World J Gastroenterol; 2005 Oct; 11(37):5899-901. PubMed ID: 16270406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
    Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular assessment of c-H-ras p21 expression in Helicobacter pylori-mediated gastric carcinogenesis.
    Sureka C; Ramesh T
    Mol Cell Biochem; 2012 Mar; 362(1-2):169-76. PubMed ID: 22045063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric microbiota in gastric cancer: Different roles of
    Guo Y; Cao XS; Zhou MG; Yu B
    Front Cell Infect Microbiol; 2022; 12():1105811. PubMed ID: 36704105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.
    Shin CM; Kim N; Park JH; Kang GH; Kim JS; Jung HC; Song IS
    J Pathol; 2012 Mar; 226(4):654-65. PubMed ID: 22252584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
    Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
    Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBX1 attributes as a determinant of connexin 32 downregulation in
    Liu XM; Xu CX; Zhang LF; Huang LH; Hu TZ; Li R; Xia XJ; Xu LY; Luo L; Jiang XX; Li M
    World J Gastroenterol; 2017 Aug; 23(29):5345-5355. PubMed ID: 28839434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: Helicobacter pylori eradication for the prevention of gastric cancer.
    De Vries AC; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():25-35. PubMed ID: 18081646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric mucosal precancerous lesions in
    Yu M; Ma J; Song XX; Shao QQ; Yu XC; Khan MN; Qi YB; Hu RB; Wei PR; Xiao W; Jia BL; Cheng YB; Kong LF; Chen CL; Ding SZ
    World J Gastroenterol; 2022 Jul; 28(28):3682-3694. PubMed ID: 36161049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric microbiota in gastric cancer and precancerous stages: Mechanisms of carcinogenesis and clinical value.
    Liao O; Ye G; Du Q; Ye J
    Helicobacter; 2023 Jun; 28(3):e12964. PubMed ID: 36880502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis.
    He C; Chen M; Liu J; Yuan Y
    Mutat Res Rev Mutat Res; 2014; 759():14-26. PubMed ID: 24076409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
    Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
    Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis.
    Liu X; Cao K; Xu C; Hu T; Zhou L; Cao D; Xiao J; Luo L; Guo Y; Qi Y
    Cancer Biol Ther; 2015; 16(6):987-96. PubMed ID: 25901741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relation between Helicobacter pylori infection and p53 mutation, MG-7 antigen and AgNORs expression in the development of gastric mucosa lesions].
    Yang GB; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1331-5. PubMed ID: 12930689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.